Overview

A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to evaluate the safety and effectiveness of liraglutide in subjects with type 2 diabetes mellitus.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide